{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:24:13Z","timestamp":1794385453641,"version":"4.9.0"},"reference-count":35,"publisher":"BMJ","issue":"11","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Duke Research Computing"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lack of a gold standard for latent TB infection has precluded direct measurement of test characteristics of the tuberculin skin test and interferon-\u03b3 release assays (QuantiFERON Gold In-Tube and T-SPOT.TB).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We estimated test sensitivity\/specificity and latent TB infection prevalence in a prospective, US-based cohort of 10\u2009740 participants at high risk for latent infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Bayesian latent class analysis was used to estimate test sensitivity\/specificity and latent TB infection prevalence among subgroups based on age, foreign birth outside the USA and HIV infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Latent TB infection prevalence varied from 4.0% among foreign-born, HIV-seronegative persons aged &lt;5 years to 34.0% among foreign-born, HIV-seronegative persons aged \u22655 years. Test sensitivity ranged from 45.8% for the T-SPOT.TB among foreign-born, HIV-seropositive persons aged \u22655 years to 80.7% for the tuberculin skin test among foreign-born, HIV-seronegative persons aged \u22655 years. The skin test was less specific than either interferon-\u03b3 release assay, particularly among foreign-born populations (eg, the skin test had 70.0% specificity among foreign-born, HIV-seronegative persons aged \u22655 years vs 98.5% and 99.3% specificity for the QuantiFERON and T-SPOT.TB, respectively). The tuberculin skin test\u2019s positive predictive value ranged from 10.0% among foreign-born children aged &lt;5 years to 69.2% among foreign-born, HIV-seropositive persons aged \u22655 years; the positive predictive values of the QuantiFERON (41.4%) and T-SPOT.TB (77.5%) were also low among US-born, HIV-seropositive persons aged \u22655 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These data reinforce guidelines preferring interferon-\u03b3 release assays for foreign-born populations and recommending against screening populations at low risk for latent TB infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT01622140\" ext-link-type=\"clintrialgov\">NCT01622140<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2018-211715","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T16:25:41Z","timestamp":1530980741000},"page":"1062-1070","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Evaluating latent tuberculosis infection diagnostics using latent class analysis"],"prefix":"10.1136","volume":"73","clinical-trial-number":[{"clinical-trial-number":"nct01622140","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01622140","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-8176","authenticated-orcid":false,"given":"Jason E","family":"Stout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April C","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jean","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly J","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thara","family":"Venkatappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,7,7]]},"reference":[{"key":"2020050723421253000_73.11.1062.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"2020050723421253000_73.11.1062.2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0491"},{"key":"2020050723421253000_73.11.1062.3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2048"},{"key":"2020050723421253000_73.11.1062.4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tube.2016.06.003","article-title":"Discriminative expression of whole blood genes in HIV patients with latent and active TB in Ethiopia","volume":"100","author":"Kassa","year":"2016","journal-title":"Tuberculosis"},{"key":"2020050723421253000_73.11.1062.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01316-1"},{"key":"2020050723421253000_73.11.1062.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01358.x"},{"key":"2020050723421253000_73.11.1062.7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10792-012-9588-3","article-title":"Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity)","volume":"32","author":"Kuznetcova","year":"2012","journal-title":"Int Ophthalmol"},{"key":"2020050723421253000_73.11.1062.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0232OC"},{"key":"2020050723421253000_73.11.1062.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00098509"},{"key":"2020050723421253000_73.11.1062.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70210-9"},{"key":"2020050723421253000_73.11.1062.11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1017\/S0950268815002149","article-title":"Latent class analysis of diagnostic tests for adenovirus, Bordetella pertussis and influenza virus infections in German adults with longer lasting coughs","volume":"144","author":"Sobotzki","year":"2016","journal-title":"Epidemiol Infect"},{"key":"2020050723421253000_73.11.1062.12","doi-asserted-by":"publisher","DOI":"10.1080\/10705510701575602"},{"key":"2020050723421253000_73.11.1062.13","doi-asserted-by":"crossref","unstructured":"Aabye MG , Ravn P , PrayGod G , et al . The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009;4:e4220. doi:10.1371\/journal.pone.0004220","DOI":"10.1371\/journal.pone.0004220"},{"key":"2020050723421253000_73.11.1062.14","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207687"},{"key":"2020050723421253000_73.11.1062.15","unstructured":"O I . T-SPOT.TB Package Insert UK version 3 Abingdon, Oxfordshire, UK2016. 2017 www.oxforddiagnosticlaboratories.eu\/wp-content\/media\/PI-TB-IVD-UK-v3.pdf (accessed 19 Oct 2017)."},{"key":"2020050723421253000_73.11.1062.16","unstructured":"Immunotec O . T-SPOT.TB Package Insert US version 5 Marlborough, MA, USA2015. 2017 www.tspot.com\/wp-content\/uploads\/2012\/10\/PI-TB-US-v5.pdf (accessed 19 Oct 2017)."},{"issue":"RR-6","key":"2020050723421253000_73.11.1062.17","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"American Thoracic Society","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"2020050723421253000_73.11.1062.18","unstructured":"Qiagen. QuantiFERON-TB Gold (QFT) ELISA Package Insert Germantown, MD, USA 2016. 2017 www.QuantiFERON.com (accessed 19 Oct 2017)."},{"key":"2020050723421253000_73.11.1062.19","doi-asserted-by":"publisher","DOI":"10.2307\/2533043"},{"key":"2020050723421253000_73.11.1062.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2001.00158.x"},{"key":"2020050723421253000_73.11.1062.21","unstructured":"Organization WH. Global Tuberculosis Report 2013. Geneva: World Health Organization, 2013:289."},{"key":"2020050723421253000_73.11.1062.22","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/INF.0b013e31827d77b7","article-title":"Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction","volume":"32","author":"Mandalakas","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2020050723421253000_73.11.1062.23","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0650"},{"key":"2020050723421253000_73.11.1062.24","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31820b07ab"},{"issue":"RR-5","key":"2020050723421253000_73.11.1062.25","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2020050723421253000_73.11.1062.26","unstructured":"Weston R , Stagg HR FD . Health Protection Agency position statement on the use of Interferon Gamma Release Assay (IGRA) tests for Tuberculosis (TB): HPA Tuberculosis Programme Board, 2012."},{"key":"2020050723421253000_73.11.1062.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir792"},{"key":"2020050723421253000_73.11.1062.28","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000432"},{"key":"2020050723421253000_73.11.1062.29","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.169805"},{"key":"2020050723421253000_73.11.1062.30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5588\/ijtld.14.0445","article-title":"Annual risk of tuberculous infection measured using serial skin testing, Orel Oblast, Russia, 1991-2005","volume":"19","author":"Yuen","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020050723421253000_73.11.1062.31","doi-asserted-by":"crossref","unstructured":"Shanaube K , Sismanidis C , Ayles H , et al . Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One 2009;4:e7749. doi:10.1371\/journal.pone.0007749","DOI":"10.1371\/journal.pone.0007749"},{"key":"2020050723421253000_73.11.1062.32","first-page":"503","article-title":"Annual risk of tuberculous infection. 1988","volume":"80","author":"Cauthen","year":"2002","journal-title":"Bull World Health Organ"},{"key":"2020050723421253000_73.11.1062.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201508-1683OC"},{"key":"2020050723421253000_73.11.1062.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2004.00187.x"},{"key":"2020050723421253000_73.11.1062.35","unstructured":"van Smeden S . Diagnostic research in the absence of a gold standard. Utrecht: University Medical Center, 2016."}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2018-211715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T02:50:01Z","timestamp":1661568601000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2018-211715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,7]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,10,15]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/thoraxjnl-2018-211715"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211715","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211715.supp2","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211715.supp1","asserted-by":"subject"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,7]]}}}